SE8700125L - SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA - Google Patents
SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIAInfo
- Publication number
- SE8700125L SE8700125L SE8700125A SE8700125A SE8700125L SE 8700125 L SE8700125 L SE 8700125L SE 8700125 A SE8700125 A SE 8700125A SE 8700125 A SE8700125 A SE 8700125A SE 8700125 L SE8700125 L SE 8700125L
- Authority
- SE
- Sweden
- Prior art keywords
- thr
- schizophenria
- psoriasis
- treatment
- short peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The compsn. includes octapeptide ala-Ser-thr-thr-thr-asn-ty r-thr or a pentapeptide thr-X-Y-tyr-thr where X and Y can be amino acids and Y is an aminoacid esp. Asp. The first thr can be d-ala. It can be administered as an intravenous, oral or topical medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8700125A SE8700125L (en) | 1987-01-15 | 1987-01-15 | SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8700125A SE8700125L (en) | 1987-01-15 | 1987-01-15 | SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8700125D0 SE8700125D0 (en) | 1987-01-15 |
SE8700125L true SE8700125L (en) | 1988-07-16 |
Family
ID=20367164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8700125A SE8700125L (en) | 1987-01-15 | 1987-01-15 | SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE8700125L (en) |
-
1987
- 1987-01-15 SE SE8700125A patent/SE8700125L/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE8700125D0 (en) | 1987-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE306931T1 (en) | SUPPRESSION OF CHANGES ASSOCIATED WITH BETA-AMYLOID IN ALZHEIMER | |
GEP20002300B (en) | Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof | |
DE69428214T2 (en) | TRANSFORMING GROWTH FACTOR ALPHA H1 | |
IT1261949B (en) | THERAPEUTIC COMPOSITION BASED ON HUMAN INTERFERONE, USE OF HUMAN INTERFERONE IN SUCH COMPOSITION AND RELATED METHOD. | |
DE69630890D1 (en) | PEPTID-IMITATING SUBSTANCES IN CANCER THERAPY | |
ATE298561T1 (en) | ORAL DOSAGE FORM | |
CA2215203A1 (en) | Vaccines for plague | |
RU95106651A (en) | Analogs of des-tyr-dinorphine and method of treatment of patient with tolerant states | |
NO871574L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PEPTIDES. | |
SE8802569L (en) | IMPROVEMENTS ON OR REGARDING SOMATOS STATINES | |
NO893088D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE SOMATOSTAT SIMILAR CYCLE PEPTID RELATIONS. | |
ZA943920B (en) | Pharmaceutical compositions | |
KR960705578A (en) | METHOD FOR TREATING HEPATITIS B CARRIERS WITH MINIMAL DISEASE | |
NO20042100D0 (en) | Method for administering a thymosinal alpha 1 peptide | |
SE8700125D0 (en) | SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA | |
DE58905768D1 (en) | METHOD FOR THE PRODUCTION OF PREPARATIVES OF BIOLOGICALLY ACTIVE PEPTIDES SUITABLE FOR RECTAL AND VAGINAL APPLICATION. | |
NO890174L (en) | RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES. | |
GR3019372T3 (en) | Peptide antagonists of bradykinin | |
KR950700737A (en) | Medicine for the treatment of airways inflammation and airways hyperresponsiveness | |
EP0235904A3 (en) | Treatment of allergy with thymopentin | |
ATE46173T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES. | |
MX9205978A (en) | NEW TOMB INHIBITOR PROTEINS OF TICKS. | |
EP0342015A3 (en) | Peptides, their use and pharmaceutical compositions containing them | |
ATA901889A (en) | METHOD FOR THE PRODUCTION OF WATER-SOLUBLE PRIMYCIN AND ITS COMPONENTS AND THEIR PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
ATE452139T1 (en) | PEPTIDE BAIT FOR THE PRODUCTION OF MEDICATIONS USED FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES OR PROBLEMS ASSOCIATED WITH THE APPEARANCE OF ANTIBODIES DIRECTED TO EXOGENE PROTEINS |